Johnson & Johnson Innovation is seeking therapeutic targets and/or therapeutic assets targeting pathways driving pro-resolution responses in innate immune cells. Specifically, the identification and assessment of therapeutic targets and pathways that drive pro-resolution responses in innate immune cells that can be used to treat autoimmune and/or chronic inflammatory diseases.
Specific Processes of Interest
- Cessation of neutrophil tissue infiltration
- Counter-regulation of chemokines and cytokines
- Induction of apoptosis in spent neutrophils while promoting...